Literature DB >> 10527524

A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.

X He1, C M Li, J H Park, A Dagan, S Gatt, E H Schuchman.   

Abstract

Acid ceramidase (N-acylsphingosine amidohydrolase) is the lysosomal enzyme required to hydrolyze the N-acyl linkage between the fatty acid and sphingosine moieties in ceramide. A deficiency of acid ceramidase activity results in the lipid storage disorder, Farber disease. This study reports a new assay method to detect acid ceramidase activity in vitro using Bodipy or lissamine rhodamine-conjugated ceramide (C12 ceramide; dodecanoylsphingosine). Using mouse kidney extracts as the source of acid ceramidase activity, this new method was compared with an assay using radioactive C12 ceramide (N-[(14)C]-dodecanoylsphingosine) as a substrate. The Bodipy C12 ceramide substrate provided data very similar to those of the radioactive substrate, but under the experimental conditions tested, it was significantly more sensitive. Using Bodipy C12 ceramide, femtomole quantities of the product, Bodipy dodecanoic acid, could be detected, providing an accurate measure of acid ceramidase activity as low as 0.1 pmol/mg protein/h. Acid ceramidase activities in skin fibroblasts and EBV-transformed lymphoblasts from Farber disease patients were around 7.8 and 10% of those in normal cells, respectively, confirming the specificity of this new assay method. Based on these results, we suggest that this fluorescence-based, high-performance liquid chromatographic technique is a reliable, rapid, and highly sensitive method to determine acid ceramidase activity, and that it could be useful wherever the in vitro detection of acid ceramidase activity is of importance. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527524     DOI: 10.1006/abio.1999.4284

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.

Authors:  Jagdeep S Walia; Anton Neschadim; Orlay Lopez-Perez; Abdulfatah Alayoubi; Xin Fan; Stéphane Carpentier; Melissa Madden; Chyan-Jang Lee; Fred Cheung; David A Jaffray; Thierry Levade; J Andrea McCart; Jeffrey A Medin
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

2.  A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.

Authors:  Carmen Bedia; Luz Camacho; José Luís Abad; Gemma Fabriàs; Thierry Levade
Journal:  J Lipid Res       Date:  2010-09-24       Impact factor: 5.922

3.  In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.

Authors:  Shobha Ramsubir; Takahiro Nonaka; Carmen Bedia Girbés; Stéphane Carpentier; Thierry Levade; Jeffrey A Medin
Journal:  Mol Genet Metab       Date:  2008-09-20       Impact factor: 4.797

4.  Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

Authors:  Raymond Y Wang; Afshin Aminian; Michael F McEntee; Shih-Hsin Kan; Calogera M Simonaro; William C Lamanna; Roger Lawrence; N Matthew Ellinwood; Catalina Guerra; Steven Q Le; Patricia I Dickson; Jeffrey D Esko
Journal:  Mol Genet Metab       Date:  2014-06-06       Impact factor: 4.797

5.  Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica.

Authors:  Nadejda V Pavlova; Su-Chen Li; Yu-Teh Li
Journal:  Glycoconj J       Date:  2017-10-16       Impact factor: 2.916

6.  Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice.

Authors:  Rajwinder Dhami; Xingxuan He; Edward H Schuchman
Journal:  Cell Physiol Biochem       Date:  2010-10-29

7.  Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.

Authors:  Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-01       Impact factor: 5.187

Review 8.  Approaches for probing and evaluating mammalian sphingolipid metabolism.

Authors:  Justin M Snider; Chiara Luberto; Yusuf A Hannun
Journal:  Anal Biochem       Date:  2019-03-24       Impact factor: 3.365

9.  Activity of neutral and alkaline ceramidases on fluorogenic N-acylated coumarin-containing aminodiols.

Authors:  Mireia Casasampere; Luz Camacho; Francesca Cingolani; Josefina Casas; Meritxell Egido-Gabás; José Luís Abad; Carmen Bedia; Ruijuan Xu; Kai Wang; Daniel Canals; Yusuf A Hannun; Cungui Mao; Gemma Fabrias
Journal:  J Lipid Res       Date:  2015-08-18       Impact factor: 5.922

10.  Deregulation of sphingolipid metabolism in Alzheimer's disease.

Authors:  Xingxuan He; Yu Huang; Bin Li; Cheng-Xin Gong; Edward H Schuchman
Journal:  Neurobiol Aging       Date:  2008-06-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.